SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-003031
Filing Date
2024-02-08
Accepted
2024-02-08 17:02:03
Documents
1
Period of Report
2024-02-06

Document Format Files

Seq Description Document Type Size
1 form4-02082024_100252.html 4  
1 form4-02082024_100252.xml 4 3475
  Complete submission text file 0001415889-24-003031.txt   4940
Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Issuer) CIK: 0001613780 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O DBV TECHNOLOGIES S.A. 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address
Ndu Adora (Reporting) CIK: 0001865210 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36697 | Film No.: 24609994